Back to search

Democritus University of Thrace (DUTH)

Μηχανισμοί δράσης προβιοτικών μικροοργανισμών σε in vitro και in vivo συστήματα

Abstract

dc:description

The term probiotics was originally used to describe substances produced by a microorganism which could confer beneficial effect on the host by contributing to its intestinal flora balance (Fuller, 1989). Until then, several definitions were used to describe probiotics. However, the official definition, was given by the Food and Agriculture Organization (FAO) and World Health Organization (WHO) according to which probiotics are defined as “live microorganisms which when administered in adequate amounts confer a health benefit on the host. (FAO/WHO, 2002).The most commonly used probiotic strains include lactic acid bacteria (LAB), such as Lactobacillus, Bifidobacterium, as well as Streptococcus species. The novel potentially probiotic strains must possess certain characteristics, including acid tolerance and resistance to bile salt hydrolysis. Furthermore, the adhesion capacity of probiotics confers great advantage by increasing their interaction with the host, however this property is not a prerequisite for their action. Moreover, any potential probiotic strain should be generally recognized as safe (GRAS) and have antimicrobial activity against pathogenic bacteria (Mercenier et al., 2008). There are numerous studies indicating the health benefits attributed to probiotics, including alleviation of the symptoms of irritable bowel syndrome and inflammatory bowel disease. In addition, there is increasing evidence that the administration of probiotics has positive impact against various health disorders, such as mental, immunological and metabolic disorders. Furthermore, it has been demonstrated both in vitro and in vivo that probiotic microorganisms could inhibit the growth of colon cancer (Orlando et al., 2016; Tiptiri-Kourpeti et al., 2016; Ma et al., 2010), as well as other forms of cancer cells such as breast cancer (Marschalek et al., 2017).The health-promoting effect of the probiotic species seems to be strain specific and is developed through a range of molecular mechanisms, such as reinforcement of the epithelial barrier, adhesion to the intestinal mucosa, competitive pathogen exclusion, production of antimicrobial agents and modulation of host immune responses (Bermudez-Brito et al., 2012).In recent years, there is a tremendous interest in isolation of new probiotic microorganisms and their application in the development of innovative functional foods. To this end, our research team in collaboration with the Laboratory of Microbiology, Biotechnology and Hygiene, Faculty of Agricultural Development, Democritus University of Thrace, isolated novel lactic acid bacteria (LAB) from Feta-type cheese, which were screened for probiotic potential in a series of established in vitro tests, including resistance to low pH, resistance to pepsin and pancreatin and tolerance to bile salts. Furthermore, the susceptibility against common antibiotics was determined to ensure a safe exploitation of the potentially probiotic strains. The strain Lactobacillus K5, which displayed the most desirable probiotic properties, was chosen for molecular genotyping and investigation of its potential probiotic activity and mechanisms of action by employing in vitro and in vivo tests. Firstly, molecular characterization indicated that Lactobacillus K5 belongs to the paracasei species. Furthermore, a novel multiplex PCR assay, based on random amplified polymorphic DNA (RAPD) analysis, was developed for its efficient and accurate detection in food products. Then, we investigated its mechanisms of action in vitro. In particular, employing quantitative analysis and confocal, fluorescent microscopy the adhesion properties of the above strain to Caco-2 colon cancer cells were studied. L. paracasei K5 displayed efficient adherence capacity to colon cancer cells, similarly to the reference strains L. casei ATCC 393 and L. rhamnosus GG. Moreover, we investigated the antiproliferative potential of L. paracasei K5 on cancer cells and we demonstrated that treatment of Caco-2 cells with L. paracasei K5 inhibited cell proliferation in a time-and dose-dependent manner. The anti-proliferative effects appear to be mediated through induction of apoptosis via modulation of transcription levels of specific Bcl-2 family proteins, which was also confirmed in protein level. Additionally, we demonstrated inhibition of growth of human colon cells after treatment with the conditioned medium of L. paracasei K5. Then, the mechanisms of action of L. paracasei K5 were further investigated in vivo by employing the dorsal-air-pouch mouse model, which is a well-established model of inflammation. We recorded an eight-fold increase in the recruitment of immune cells in mice treated with the potentially probiotic strain, compared to the control group. Analysis of the exudates revealed significant changes in the expression of pro-inflammatory mediators on site. Furthermore, treatment of Caco-2 cells with L. paracasei K5 induced significant upregulation of cytokines interleukin-1α (IL-1α), ΙL-1β, IL-6, tumor necrosis factor-alpha (TNF-α), the chemokine C-X-C motif ligand 2 (CXCL2), and the inflammation markers soluble intercellular adhesion molecule (sICAM) and metallopeptidase inhibitor-1 (TIMP-1). Transient induction of the Toll-like receptors (TLRs) 2, 4, 6, and 9 expression levels was also recorded by real-time PCR analysis. These results highlight the immunomodulatory potential of this strain and further support its probiotic character.In summary, in this study the probiotic potential of a novel Lactobacillus strain was investigated both in vitro and in vivo. Our results show that L. paracasei K5 displays significant probiotic properties and it may be used for the development of novel functional foods in furture studies.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chondrou, Pelagia
  • Χονδρού, Πελαγία

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49222

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chondrou, Pelagia; Χονδρού, Πελαγία. Μηχανισμοί δράσης προβιοτικών μικροοργανισμών σε in vitro και in vivo συστήματα. Democritus University of Thrace (DUTH), 2021. http://hdl.handle.net/10442/hedi/49222